Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 76: 1528-1532, 1994;
8750-7587/94 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Sanctis, G. T.
Right arrow Articles by Remmers, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Sanctis, G. T.
Right arrow Articles by Remmers, J. E.

Journal of Applied Physiology, Vol 76, Issue 4 1528-1532, Copyright © 1994 by American Physiological Society

ARTICLES

Ventilatory responses to hypoxia in rats pretreated with nonpeptide NK1 receptor antagonist CP-96,345

G. T. De Sanctis, F. H. Green, X. Jiang, M. King and J. E. Remmers
Department of Internal Medicine, University of Calgary, Alberta, Canada.

This study reports experiments designed to evaluate the role of neurokinin-1 (NK1) receptors for substance P (SP) in the ventilatory response to acute hypoxia. Ventilation was measured by indirect plethysmography in eight unanesthetized unrestrained adult rats before and after bolus injection of 1, 5, or 10 mg/kg (ip) of CP-96,345 (Pfizer), a potent nonpeptide competitive antagonist of the SP NK1 receptor. Ventilation was measured while the rats breathed air or 8% O2-92% N2 with and without administration of SP antagonist. Pretreatment with CP-96,345 decreased the magnitude of the hypoxic response in a dose-dependent fashion. Minute ventilation in rats pretreated with CP-96,345 was reduced by 22.1% (P < 0.05) at the highest dose (10 mg/kg), largely because of an attenuation of the frequency component. Although both control and treated rats responded to hypoxia with a decrease in duration of inspiration and expiration rats pretreated with CP-96,345 displayed a smaller decrease in inspiration and expiration than control rats (P < 0.05). We have recently shown that neuropeptide-containing fibers are important for mediating the tachypnic response during acute isocapnic hypoxia in rats. The attenuation in minute ventilation at the highest dose (10 mg/kg) is comparable in magnitude to the attenuation observed with neonatal capsaicin treatment, which permanently ablates neuropeptide-containing unmyelinated fibers. Accordingly, this previously reported role of capsaicin-sensitive nerves in the hypoxic ventilatory response of rats is probably attributable to released SP acting at NK1 receptors. One of the likely sites of action of SP antagonists is the carotid body.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
 J. Physiol.Home page
C. Morgado-Valle and J. L. Feldman
Depletion of substance P and glutamate by capsaicin blocks respiratory rhythm in neonatal rat in vitro
J. Physiol., March 15, 2004; 555(3): 783 - 792.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
G. K. Kumar, Y. R. Kou, J. L. Overholt, and N. R. Prabhakar
Involvement of substance P in neutral endopeptidase modulation of carotid body sensory responses to hypoxia
J Appl Physiol, January 1, 2000; 88(1): 195 - 202.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
H. Grasemann, B. Lu, A. Jiao, J. Boudreau, N. P. Gerard, and G. T. De Sanctis
Targeted deletion of the neutral endopeptidase gene alters ventilatory responses to acute hypoxia in mice
J Appl Physiol, October 1, 1999; 87(4): 1266 - 1271.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online